Molecular Microbiology’s Women’s Health Testing system

The Defense Health Agency is seeking a firm-fixed-price contract for a high-volume molecular microbiology nucleic acid amplification testing system for the Naval Medical Center Portsmouth in Virginia. The solicitation, numbered HT940625R0011, requires a comprehensive testing solution that includes software licenses, services, support, and maintenance for an instrument system capable of interfacing with the MHS Genesis electronic health record system. The procurement will focus on Women's Health testing, including assays for Chlamydia/Gonorrhea, Trichomonas, and HPV. Proposals will be evaluated based on technical approach, past performance, price, and business factors, with technical approach being the most critically weighted element. The solicitation is being conducted via full and open competition, with proposals due by May 30, 2025, and all responses must comply with Federal Acquisition Circular 2024-03 provisions.

The contract will have a base period from July 1, 2025 to June 30, 2026, with four potential 12-month option periods that could extend services through June 30, 2030, and a possible 6-month extension thereafter. No specific set-aside has been designated for this opportunity, and the procurement falls under NAICS code 334516 for Analytical Laboratory Instrument Manufacturing with a $6 million size standard. The vendor will be required to provide two analyzer systems and one aliquoting sample processing system, with all equipment remaining the vendor's property. The place of performance is Portsmouth, VA, and the solicitation anticipates procuring various testing kits and supplies, including approximately 21-34 different molecular testing products with quantities ranging from 6 to 277 kits. The total contract value is structured as a cost-per-test model with reagents and maintenance services included.